Market Currents
The Street's Adam Feuerstein makes 13 biotech stock predictions for 2013, with his number one...
-
Wednesday, January 2, 9:44 AM ETThe Street's Adam Feuerstein makes 13 biotech stock predictions for 2013, with his number one being that the U.S. launch of Arena Pharmaceuticals' (ARNA) and Eisai's weight-loss pill Belviq "will be a major disappointment." Feuerstein also reckons that Belviq will fail to receive European approval.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 17 comments:
Here's a reminder to Adam Feuerstein's Biotech Stock Predictions for 2012:
http://bit.ly/Umi97C
And here's what he wrote in his prediction for ARNA (and VVUS for that matter): "FDA rejects obesity drugs from Arena Pharmaceuticals (ARNA_) and Vivus (VVUS_) for a second time. "
He got it wrong then and he gets it wrong now.
Follow your brain and heart, follow your own analysis.
Don't follow peope who think that they understand biotech better than you simply because they received a pen and a paper to write about a sunject they don't know much about...
What is his momentous declaration based on now? What research or data? Anything?
"Adumb"
Pretty much sums it up......
http://bit.ly/Umi97C
We will find out soon.
Let's hope Seeking Alpha allows this comment as my feelings do have merit.